111 Inc. Bolsters Supply Chain with New Fulfillment Centers in South and Central China

111 Inc., a leading tech-enabled healthcare platform in China, has expanded its national supply chain network with the opening of new fulfillment centers in Guangzhou and Wuhan. This strategic move aims to enhance supply chain efficiency, improve customer reach, and strengthen the company's competitive position in the Chinese healthcare market.

The new centers in South and Central China enable 111 Inc. to reduce operating costs and improve delivery efficiency through innovative operational models. By utilizing a newly designed operational model, these centers significantly reduce operating costs while expanding warehousing capacity with higher cost efficiency. This results in faster and more efficient operations, with most deliveries now being fulfilled within 24 hours.

The expansion of 111 Inc.'s fulfillment centers supports the company's goal of delivering to over 300 major cities nationwide within 24 hours and covering the entire nation within 72 hours. With a stronger national supply chain network, 111 Inc. is well-positioned to meet growing market demand and provide seamless logistics services to partners across the supply chain.

The new fulfillment centers also contribute to 111 Inc.'s competitive position in the Chinese healthcare market. By integrating cutting-edge technology and operational innovation, the company can further enhance its delivery speed, reduce costs, and improve overall efficiency. These centers not only reinforce the company's market presence in key regions but also support its vision of becoming the go-to platform for pharmaceutical products with the best selection and prices across China.

In conclusion, 111 Inc.'s expansion of fulfillment centers in South and Central China is a critical step in strengthening its supply chain and delivering exceptional service to customers. The innovative operational models and technological upgrades enable the company to improve delivery efficiency, reduce costs, and maintain a competitive edge in the Chinese healthcare market.